Treatment of Lennox-Gastaut syndrome

Authors

  • Iliyana Aleksandrova UHATNP "St.Naum"; Medical university – Sofia
  • V. Bojinova UHATNP "St.Naum"; Medical university – Sofia

Keywords:

Lennox-Gastaut syndrome, therapeutic resistance, rufinamide, topiramate, lamotrigine

Abstract

Lennox-Gastaut syndrome is a severe epileptic encephalopathy, characterized by a therapeutic resistance. The therapy is significantly complicated by the persistence of polymorphic seizures. The antiepileptic drugs help to reduce the seizure frequency and improve the quality of life of the patients, but rarely a complete remission of the seizures is achieved. Rufinamide, lamotrigine, topiramate and benzodiazepines are the first line add-on drugs. The treatment of each patient is individual and is guided by the potential benefits and the possible side effects of the antiepileptic drugs.

References

Arzimanoglou, A., French, J., Blume, WT. et al. Lennox–Gastaut syndrome: a consensus approach on diagnosis, assessment, management and trial methodology. Lancet Neurol, 2009, 8, 1, 82–93.

Chamberlain, M. Nitrazepam for Refractory Infantile Spasms and the Lennox-Gastaut Syndrome. J Child Neurol, 1996, 11, 1, 31-34.

Conry, J., Ng, Y., Paolicchi, J. et al. Clobazam in the treatment of Lennox–Gastautsyndrome. Epilepsia, 2009, 50, 5, 1158–1166.

Coppola, G., Caliendo, G., Veggioti, P. et al. Topiramate as addon drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study. Epilepsy Res, 2001, 51, 1-2, 147-153.

Dodson, W. Felbamate in the treatment of Lennox–Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial. Epilepsia, 1993, 34, Suppl.7, 18–24.

Donaldson, L., Glauser, T., Olberding. L. Lamotrigine Adjunctive Therapy in Childhood Epileptic Encephalopathy (the Lennox Gastaut Syndrome). Epilepsia, 1997, 38, 1, 68-73.

Dulac, O., Kaminska, A. Use of Lamotrigine in Lennox-Gastaut and related epilepsy syndromes. J Child Neurol, 1997, 12, Suppl.1, 23-28.

Felbamate Study Group in Lennox–Gastaut syndrome. Еfficacy of felbamate in childhood epileptic encephalopathy (Lennox–Gastaut syndrome). N Engl J Med, 1993, 328, 29–33.

Glauser, T., Levisohn, P., Ritter, F. et al. Topiramate in Lennox–Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia, 2000, 41, Suppl.1, 86–90.

Glauser, T., Kluger, G., Sachdeo, R. et al. Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome. Neurology, 2008, 70, 21, 1950–1958.

Guerreiro, M., Manreza, M., Scotoni, A. et al. A pilot study of topiramate in children with Lenox-Gastaut syndrome. Arq. Neuropsiquiatr, 1999, 57, 2A, 167-175

Hancock, E., Cross, H. Treatment of Lennox-Gastaut. Cochrane Database Syst Rev, 2013, 28, 2.

Kluger, G., Glauser, T., Krauss, G. et al. Adjunctive rufinamide in Lennox–Gastaut syndrome: a long-term, open-label extension study. Acta Neurol Scand 2010, 122, 3, 202–208.

Leahy, J., Chu-Shore, C., Fisher, J. Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome. Neuropsychiatr Dis Treat, 2011, 7, 673–681.

Lee, E., Yum, M., Ko, T. Effectiveness and tolerability of rufinamide in children and young adults with Lennox–Gastaut syndrome: A single center study in Korea. Clin Neurol Neurosurg, 2013, 115, 7, 926-929.

Montouris, G. Rational approach to treatment options for Lennox-Gastaut. Epilepsia, 2011, 52, Suppl.5, 10-20.

Montouris, G., Wheless, J., Glauser, T. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome. Epilepsia, 2014, 55, Suppl.4, 10-20.

Moreland, E., Griesemer, D., Holden, K. Topiramate for intractable childhood epilepsy. Seizure, 1999, 8, 1, 38-40.

Motte, J., Trevathan, E., Arvidsson, J. et al. Lamotrigine for generalized seizures associated with the Lennox–Gastaut syndrome. N Engl J Med, 1997, 337, 25, 1807–1812.

Ng, Y., Conry, J., Drummond, R. et al. Randomized, phase III study results of clobazam in Lennox–Gastaut syndrome. Neurology, 2011, 77, 15, 1473–1481.

Ng Y., Conry J, Paolicchi J, et al. Long-term safety and efficacy of clobazam for Lennox–Gastaut syndrome: interim results of an open-label extension study. Epilepsy Behav, 2012, 25, 4, 687–694.

Ohtsuka, Y., Yishinaga, H., Shirasaka, Y. et al. Rufinamide as an adjunctive therapy for Lennox–Gastaut syndrome: A randomized double-blind placebo-controlled trial in Japan. Epilepsy research, 2014, 108, 9, 1627-1636.

Reyes, E., Sharp, G., Williams, J., Hale, S. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol, 2004, 30, 4, 254-256.

Rijckevorsel, K. Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatric Disease and Treatment, 2008, 4, 6, 1001–1019.

Sachdeo, R., Glauser, T., Ritter, F. et al. A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome. Neurology, 1999, 52, 9, 1882–1887.

Tassinari, C., Dravet, C., Roger, J. et al. Tonic status epilepticus precipitated by intravenous benzodiazepines in five patients with Lennox-Gastaut syndrome. Epilepsia, 1972, 13, 3, 421-35.

Timmings, P., Richens, A. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome. Eur Neurol, 1992, 32, 305-307.

You, S., Kang, H., Kim, H. et al. Clinical efficacy of zonisamide in Lennox–Gastaut syndrome: Korean multicentric experience. Brain, Dev 2008, 30, 4, 287–290.

Vanstraten, A., Ng, Y. Update on the management of Lennox– Gastaut syndrome. Pediatr Neurol, 2012, 47, 3, 153–161.

Vassella, F., Pavlincova, E., Schneider, H. et al. Treatment of infantile spasms and Lennox–Gastaut syndrome with clonazepam (Rivotril). Epilepsia, 1973, 14, 2, 165–175.

Published

30.12.2017

How to Cite

Aleksandrova, Iliyana, and V. Bojinova. “Treatment of Lennox-Gastaut Syndrome”. Cephalgia, vol. 19, no. 2, Dec. 2017, pp. 24-30, https://cephalgia.org/index.php/ce/article/view/21.

Issue

Section

CEPHALGIA